Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127041221 | 12704122 | 1 | I | 2012 | 20160825 | 20160831 | 20160831 | EXP | BR-009507513-1608BRA014438 | MERCK | 39.00 | YR | F | Y | 84.00000 | KG | 20160831 | LW | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127041221 | 12704122 | 1 | PS | NUVARING | ETHINYL ESTRADIOLETONOGESTREL | 1 | UNK, 3 WEEKS WITH THE VAGINAL RING AND ONE WEEK FREE | N | 21187 | VAGINAL RING | |||||||||
| 127041221 | 12704122 | 2 | SS | NUVARING | ETHINYL ESTRADIOLETONOGESTREL | 1 | Vaginal | UNK,3 WEEKS WITH THE VAGINAL RING AND ONE WEEK FREE | N | 21187 | VAGINAL RING | ||||||||
| 127041221 | 12704122 | 3 | SS | NUVARING | ETHINYL ESTRADIOLETONOGESTREL | 1 | Vaginal | UNK,3 WEEKS WITH THE VAGINAL RING AND ONE WEEK FREE | N | 21187 | VAGINAL RING | ||||||||
| 127041221 | 12704122 | 4 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | UNK | 0 | |||||||||||
| 127041221 | 12704122 | 5 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 0 | ||||||||||||
| 127041221 | 12704122 | 6 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | TABLET | QD | |||||
| 127041221 | 12704122 | 7 | SS | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 80MG, 2 TABLETS DAILY | U | 0 | TABLET | ||||||||
| 127041221 | 12704122 | 8 | SS | FRONTAL | ALPRAZOLAM | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127041221 | 12704122 | 1 | Contraception |
| 127041221 | 12704122 | 4 | Anxiety |
| 127041221 | 12704122 | 5 | Panic disorder |
| 127041221 | 12704122 | 6 | Anxiety |
| 127041221 | 12704122 | 7 | Anxiety |
| 127041221 | 12704122 | 8 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127041221 | 12704122 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127041221 | 12704122 | Affective disorder | |
| 127041221 | 12704122 | Anxiety | |
| 127041221 | 12704122 | Disturbance in attention | |
| 127041221 | 12704122 | Drug effect decreased | |
| 127041221 | 12704122 | Dysgraphia | |
| 127041221 | 12704122 | Hypothyroidism | |
| 127041221 | 12704122 | Insomnia | |
| 127041221 | 12704122 | Panic disorder | |
| 127041221 | 12704122 | Pregnancy on contraceptive | |
| 127041221 | 12704122 | Reading disorder | |
| 127041221 | 12704122 | Unintended pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127041221 | 12704122 | 1 | 2010 | 20160417 | 0 | |
| 127041221 | 12704122 | 2 | 20160424 | 20160515 | 0 | |
| 127041221 | 12704122 | 3 | 201605 | 20160527 | 0 | |
| 127041221 | 12704122 | 4 | 2012 | 201406 | 0 | |
| 127041221 | 12704122 | 6 | 20160527 | 0 | ||
| 127041221 | 12704122 | 7 | 20160527 | 0 | ||
| 127041221 | 12704122 | 8 | 20160527 | 0 |